These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 20601656)

  • 1. Macrophage activation syndrome after leflunomide treatment in an adult rheumatoid arthritis patient.
    Ricci M; Rossi P; De Marco G; Varisco V; Marchesoni A
    Rheumatology (Oxford); 2010 Oct; 49(10):2001. PubMed ID: 20601656
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk of interstitial lung disease associated with leflunomide treatment in Korean patients with rheumatoid arthritis.
    Ju JH; Kim SI; Lee JH; Lee SI; Yoo WH; Choe JY; Chung SH; Lee J; Lee YH; Lee SS; Yoon HJ; Yoon CH; Kim HY; Park SH
    Arthritis Rheum; 2007 Jun; 56(6):2094-6. PubMed ID: 17530652
    [No Abstract]   [Full Text] [Related]  

  • 3. Pulmonary hypertension in a patient with rheumatoid arthritis treated with leflunomide.
    Martinez-Taboada VM; Rodriguez-Valverde V; Gonzalez-Vilchez F; Armijo JA
    Rheumatology (Oxford); 2004 Nov; 43(11):1451-3. PubMed ID: 15501999
    [No Abstract]   [Full Text] [Related]  

  • 4. Leflunomide-induced peripheral neuropathy.
    Kho LK; Kermode AG
    J Clin Neurosci; 2007 Feb; 14(2):179-81. PubMed ID: 17107800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leflunomide (Arava)-induced cystoid macular oedema.
    Barak A; Morse LS; Schwab I
    Rheumatology (Oxford); 2004 Feb; 43(2):246-8. PubMed ID: 14739469
    [No Abstract]   [Full Text] [Related]  

  • 6. Dihydroorotate dehydrogenase polymorphism influences the toxicity of leflunomide treatment in patients with rheumatoid arthritis.
    Grabar PB; Rozman B; Logar D; Praprotnik S; Dolzan V
    Ann Rheum Dis; 2009 Aug; 68(8):1367-8. PubMed ID: 19605743
    [No Abstract]   [Full Text] [Related]  

  • 7. Severe aplastic anaemia following leflunomide therapy.
    Wüsthof M; Smirnova A; Bacher U; Kröger N; Zander AR; Schuch G; Bokemeyer C
    Rheumatology (Oxford); 2010 May; 49(5):1016-7. PubMed ID: 20032226
    [No Abstract]   [Full Text] [Related]  

  • 8. Neuropathy associated with leflunomide: a case series.
    Martin K; Bentaberry F; Dumoulin C; Longy-Boursier M; Lifermann F; Haramburu F; Dehais J; Schaeverbeke T; Bégaud B; Moore N
    Ann Rheum Dis; 2005 Apr; 64(4):649-50. PubMed ID: 15769926
    [No Abstract]   [Full Text] [Related]  

  • 9. Leflunomide-induced subacute cutaneous lupus erythematosus.
    Goëb V; Berthelot JM; Joly P; Mejjad O; de Quatrebarbes J; Reynaud-Hautin C; Vittecoq O; Le Loët X
    Rheumatology (Oxford); 2005 Jun; 44(6):823-4. PubMed ID: 15757964
    [No Abstract]   [Full Text] [Related]  

  • 10. Peripheral neuropathy in patients on leflunomide.
    Bharadwaj A; Haroon N
    Rheumatology (Oxford); 2004 Jul; 43(7):934. PubMed ID: 15213340
    [No Abstract]   [Full Text] [Related]  

  • 11. Leflunomide in active rheumatoid arthritis: a prospective study in daily practice.
    Van Roon EN; Jansen TL; Mourad L; Houtman PM; Bruyn GA; Griep EN; Wilffert B; Tobi H; Brouwers JR
    Br J Clin Pharmacol; 2004 Aug; 58(2):201-8. PubMed ID: 15255803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of antinuclear antibodies in patients with rheumatoid arthritis treated with infliximab and leflunomide.
    Bingham SJ; Buch MH; Kerr MA; Emery P; Valadäo Barcelos AT
    Arthritis Rheum; 2004 Dec; 50(12):4072-3. PubMed ID: 15593202
    [No Abstract]   [Full Text] [Related]  

  • 13. Severe hypertriglygeridemia in a rheumatoid arthritis patient treated with leflunomide.
    Spanakis EK; Katsikas GA; Sidiropoulos PI; Kritikos HD
    Clin Exp Rheumatol; 2008; 26(2):382. PubMed ID: 18565269
    [No Abstract]   [Full Text] [Related]  

  • 14. Rheumatoid arthritis patients with therapy-induced myelodysplastic syndrome present with long-term remission after recovery.
    Thonhofer R; Kriessmayr M; Thonhofer U; Wipfler E; Uitz E; Bahadori B; Eder S
    Scand J Rheumatol; 2007; 36(2):149-51. PubMed ID: 17476623
    [No Abstract]   [Full Text] [Related]  

  • 15. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
    Cohen S; Cannon GW; Schiff M; Weaver A; Fox R; Olsen N; Furst D; Sharp J; Moreland L; Caldwell J; Kaine J; Strand V
    Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leflunomide-associated infections in rheumatoid arthritis.
    Jenks KA; Stamp LK; O'Donnell JL; Savage RL; Chapman PT
    J Rheumatol; 2007 Nov; 34(11):2201-3. PubMed ID: 17937473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage activation syndrome associated with etanercept in a child with systemic onset juvenile idiopathic arthritis.
    Nádia EA; Carvalho JF; Bonfá E; Lotito AP; Silva CA
    Isr Med Assoc J; 2009 Oct; 11(10):635-6. PubMed ID: 20077954
    [No Abstract]   [Full Text] [Related]  

  • 18. The hemophagocytic syndrome/macrophage activation syndrome: a final common pathway of a cytokine storm.
    Szyper-Kravitz M
    Isr Med Assoc J; 2009 Oct; 11(10):633-4. PubMed ID: 20077953
    [No Abstract]   [Full Text] [Related]  

  • 19. Safety overview of new disease-modifying antirheumatic drugs.
    Cush JJ
    Rheum Dis Clin North Am; 2004 May; 30(2):237-55, v. PubMed ID: 15172038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leflunomide, a new disease-modifying drug for treating active rheumatoid arthritis in methotrexate-controlled phase II clinical trial.
    Bao C; Chen S; Gu Y; Lao Z; Ni L; Yu Q; Xu J; Li X; Liu J; Sun L; He P; Ma J; Xu S; Ding C
    Chin Med J (Engl); 2003 Aug; 116(8):1228-34. PubMed ID: 12935395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.